Skip to main content

Table 3 The molecular and pharmacological properties data of luteolin

From: Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma

 

MW

AlogP

Hdon

Hacc

OB (%)

Caco-2

BBB

DL

FASA-

TPSA

RBN

HL

Luteolin

286.25

2.07

4

6

36.16

0.19

-0.84

0.25

0.39

111.13

 1

15.94

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us